Regulation of renal cell carcinoma cell proliferation, invasion and metastasis by connexin 32 gene

被引:24
作者
Sato, H.
Hagiwara, H.
Ohde, Y.
Senba, H.
Virgona, N.
Yano, T.
机构
[1] Natl Inst Hlth & Nutr, Project Complementary Factors, Shinjuku Ku, Tokyo 1628636, Japan
[2] Chiba Univ, Grad Sch Pharmaceut Sci, Chiba 2608675, Japan
[3] Japan Hlth Sci Fdn, Tokyo 1030001, Japan
关键词
connexin; 32; renal cell carcinoma; tumor-suppressive effect; cell proliferation; invasion; metastasis; gap junctional intercellular communication;
D O I
10.1007/s00232-007-9020-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Gap junctions composed of connexin (Cx), a large protein family with a number of subtypes, are a main apparatus to maintain cellular homeostasis in many organs. Gap junctional intercellular communication (GJIC) is actively involved in all aspects of the cellular life cycle, ranging from cell growth to cell death. It is also known that the Cx gene acts as a tumor-suppressor due to the maintenance of cellular homeostasis via GJIC. In addition to this function, recent data show that the GJIC-independent function of Cx gene contributes to the tumor-suppressive effect of the gene with specificity to certain cells. With respect to the tumor-suppressive effects, Cx genes acts as tumor-suppressors in primary cancers, but the effects are still conflicting in invasive and metastatic cancers. We have previously reported that Cx32 is specifically downregulated in human renal cell carcinoma (RCC) cell lines as well as cancerous regions when compared to normal regions in kidneys. In recent studies, we have also reported that Cx32 suppresses growth, invasion and metastasis of RCC cells. In this minireview, we refer to a new aspect of Cx32-dependent functions against cell proliferation, invasion and metastasis in RCC cells, especially in a GJIC-independent manner.
引用
收藏
页码:17 / 21
页数:5
相关论文
共 48 条
  • [1] Biochemical, cellular, and pharmacological aspects of the multidrug transporter
    Ambudkar, SV
    Dey, S
    Hrycyna, CA
    Ramachandra, M
    Pastan, I
    Gottesman, MM
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1999, 39 : 361 - 398
  • [2] Determinants of drug delivery and transport to solid tumors
    Au, JLS
    Jang, SH
    Zheng, J
    Chen, CT
    Song, S
    Hu, L
    Wientjes, MG
    [J]. JOURNAL OF CONTROLLED RELEASE, 2001, 74 (1-3) : 31 - 46
  • [3] BOND SL, 1994, CELL GROWTH DIFFER, V5, P179
  • [4] Angiogenic and cell survival functions of Vascular Endothelial Growth Factor (VEGF)
    Byrne, AM
    Bouchier-Hayes, DJ
    Harmey, JH
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2005, 9 (04) : 777 - 794
  • [5] Dioxygenases as O2-dependent regulators of the hypoxic response pathway
    Dann, CE
    Bruick, RK
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 338 (01) : 639 - 647
  • [6] FITZGERALD DJ, 1990, TERATOGEN CARCIN MUT, V10, P89
  • [7] Seminars in medicine of the Beth Israel Hospital, Boston - Clinical applications of research on angiogenesis
    Folkman, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (26) : 1757 - 1763
  • [8] Connexin32 as a tumor suppressor gene in a metastatic renal cell carcinoma cell line
    Fujimoto, E
    Sato, H
    Shirai, S
    Nagashima, Y
    Fukumoto, K
    Hagiwara, H
    Negishi, E
    Ueno, K
    Omori, Y
    Yamasaki, H
    Hagiwara, K
    Yano, T
    [J]. ONCOGENE, 2005, 24 (22) : 3684 - 3690
  • [9] Negative growth control of renal cell carcinoma cell by Connexin 32: Possible involvement of Her-2
    Fujimoto, E
    Satoh, H
    Negishi, I
    Ueno, K
    Nagashima, Y
    Hagiwara, K
    Yamasaki, H
    Yano, T
    [J]. MOLECULAR CARCINOGENESIS, 2004, 40 (03) : 135 - 142
  • [10] Grunstein J, 1999, CANCER RES, V59, P1592